Thursday January 01, 1970
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.
Speakers
Explore similar sessions
What is the right model for telemedicine
The unexpected and dramatic fall of telehealth startup Babylon in 2023 highlighted the fragility of the telemedicine model. Despite strong revenue, profitability and therefore sustainability is put into question. So,...
What is the right model for telemedicine
The unexpected and dramatic fall of telehealth startup Babylon in 2023 highlighted the fragility of the telemedicine model. Despite strong revenue, profitability and therefore sustainability is put into question. So, what is the right business model for telemedicine and what lessons have been learnt from Babylon and other telemedicine provider troubles. This session features CEOs of a telemedicine provider, primary care group and pharmacy group to share their models, discuss reimbursement, growth and how to make the telemedicine model profitable.
Speakers
Sector in focus: Diagnostic imaging
This sector has seen a huge M&A boom as investors seek to consolidate Western Europe. governments are also pumping money into the sector to increase access to diagnosis and bring...



Sector in focus: Diagnostic imaging
This sector has seen a huge M&A boom as investors seek to consolidate Western Europe. governments are also pumping money into the sector to increase access to diagnosis and bring down waiting times. What’s driving domestic and cross-border consolidation? Where are the new market opportunities?
Speakers include:
Dr Arjun Kalyanpur, CEO, Teleradiology Solutions
Speakers



The new healthcare powerhouse: MENA
The Middle East, particularly the UAE and Saudi Arabia are dominating headlines. Be it Abu Dhabi’s Pure Health’s acquisition of Circle or the gigantic PPP projects of Saudi’s Vision 2030,...
The new healthcare powerhouse: MENA
The Middle East, particularly the UAE and Saudi Arabia are dominating headlines. Be it Abu Dhabi’s Pure Health’s acquisition of Circle or the gigantic PPP projects of Saudi’s Vision 2030, there is a buzz of excitement from investors and providers, but still a large amount of uncertainty. This session, together with a detailed market overview, brings together providers and investors from MENA to discuss what the opportunity is and the best strategies to pursue them.